|
A1
Melanoma HMB-45
(Malignant
Melanoma, Brain metastasis, stage IV)
|
B1
EGFR
(Breast
Carcinoma)
|
C1
EPCAM
(Metastatic
Breast Cancer from Pleural Effusion)
|
D1
HER-2 neu
(Metastatic
Breast Cancer from Pericardial Effusion)
|
E1
Ki-67
(Cervical
Cancer)
|
F1
Ki-67
(Metastatic
Prostate Cancer from Lymph Node)
|
G1
CD8
(Acute
Lymphoblastic Leukemia)
|
H1
B7-H3
(Mesothelioma)
|
|
A2
Melanoma HMB-45
(Malignant
Melanoma, Lymph node metastasis, stage III)
|
B2
Ki-67
(Breast
Ductal Carcinoma)
|
C2
ER
(Metastatic
Breast Cancer from Pleural Effusion)
|
D2
CK-cocktail
(Metastatic
Breast Cancer from Pleural Effusion)
|
E2
Ki-67
(Cervical Cancer Adenocarcinoma)
|
F2
CK-Cocktail
(Colorectal Adenocarcinoma)
|
G2
LAG-3
(Myelomonocytic
Leukemia)
|
H2
ALK-1
(Non-Small
Cell Lung cancer)
|
|
A3
Melanoma HMB-45
(Metastatic
Melanoma, derived from metastasis to skin)
|
B3
Her-2
(Metastatic
Breast Cancer from Pleural Effusion)
|
C3
CK-cocktail
(Metastatic
Breast Cancer from Pleural Effusion)
|
D3
Myogenin
(Rhabdomyosarcoma)
|
E3
Ki-67
(Epidermoid cervical Cancer Metastasis)
|
F3
LAG-3
(Embryonic
Kidney)
|
G3
CD117
(Acute
Myelogenous Leukemia)
|
H3
EPCAM
(Lung Cancer)
|
|
A4
Melanoma HMB-45
(Malignant
Melanoma, Skin)
|
B4
PR
(Ductal Breast
Cancer)
|
C4
PR
(Metastatic
Breast Cancer from Pleural Effusion)
|
D4
Neuroblastoma
(Neuroblastoma
Derived form Bone Marrow Metastasis)
|
E4
Neuroblastoma
(Neuroblastoma)
|
F4
CTLA-4
|
